CBI Scene Blog

Sabrina Delio

Recent Posts

Virtual Meeting vs. Destination Meeting: Which is the Right Choice?

Posted by Sabrina Delio on Dec 5, 2017 3:00:00 PM

Meetings are an inevitability of the pharmaceutical world, but that doesn't mean that a single format is always the clear winner. There are advantages - and disadvantages - to both in-person (destination) and digital (virtual) meeting formats; the right choice for your needs will depend on several important factors, such as:

Read More

From Stoop To Stage: Pharma Forum 2018 Keynote Announced

Posted by Sabrina Delio on Nov 7, 2017 4:02:00 PM

Cat Greenleaf, creator/host of the award-winning series Talk Stoop on both NBC & USA Networks is confirmed to deliver the keynote address at the 14th Annual Pharma Forum Conference.

Read More

3 More Tips for Planning and Executing Compliant and Successful Life Sciences Meetings

Posted by Sabrina Delio on Oct 31, 2017 2:00:00 PM

Don't let the fear of non-compliance
scare you this Halloween!

When entering the world of life sciences meeting management, take the time to establish a course of action that works best for you and helps set you up for future success. 

Our last article, "5 Tips for Combating Compliance and Policy Challenges in the Execution of Global Pharmaceutical Meetings," addressed critical tricks for compliantly designing your meeting within regulatory limitations.

We talked to Michelle Bartolone, CMP, Chief Executive Officer, Meeting Sites Pro, Inc., who provided us with 3 more tips to add to your toolbox!:

Read More

Topics: meeting professionals, Meeting Management

Establishing HCP Meal Limits for Life Sciences Meetings

Posted by Sabrina Delio on Oct 3, 2017 3:02:00 PM

Discover How U.S. Pharmaceutical/Biotechnology Companies Establish Dollar Limits for HCP Meals

As you know, meal caps are ubiquitous in the world of life sciences meetings and can often be an obstacle to successful negotiations between meeting managers and their hospitality partners.

Read More

Topics: meeting professionals, Meeting Management

The Best and Brightest: A Peek into the Pharma Forum Audience

Posted by Sabrina Delio on Sep 26, 2017 12:00:00 AM

If you find yourself asking who attends the world’s leading life sciences meeting management forum, look no further. From corporate and third-party planners, to their supplier and DMC partners, Pharma Forum continues to attract the largest and most diverse audience of pharmaceutical meeting management professionals. Take a look below to see who attended in 2017!

Read More

Topics: meeting professionals, Meeting Management

A Letter from the Pharma Forum Program Director

Posted by Sabrina Delio on Sep 19, 2017 4:03:00 PM

The Thought Behind the Theme: Infuse, Invoke, Ignite.

Earlier this summer, I sat down with the Pharma Forum team to brainstorm the aspects of what separates planning life sciences meetings from any other industry, and why it is so critical to come together in a meaningful forum of knowledge exchange and collaboration. As planners, suppliers and partners who support the creation and execution of hundreds of thousands of meetings every year, how do we make our meetings impactful? How do we execute them flawlessly? How do we ensure attendees have a positive engagement experience? The brainstorm led us to the terms: infuse, invoke and ignite to embody what Pharma Forum and life sciences meeting management are truly about.

Read More

Meet Pharma Forum's 2018 Advisory Board

Posted by Sabrina Delio on Sep 6, 2017 8:19:00 AM

 

Read More

Topics: meeting professionals, Meeting Management

Pharma Forum's 2018 CSR Activity: TOMS® shoes

Posted by Sabrina Delio on Aug 25, 2017 10:00:07 AM

 

Read More

Topics: meeting professionals, Meeting Management

Launching an Orphan Drug: A Case Study by AmerisourceBergen

Posted by Sabrina Delio on Dec 9, 2016 2:31:24 PM

 

Read More

Topics: Patient Access, Rare Disease & Orphan Drugs, product launch

Q&A With Executive Director of the Center for Lawful Access and Abuse Deterrence (CLAAD) on the Challenges and Future of ADFs

Posted by Sabrina Delio on Mar 8, 2016 10:46:19 AM

We recently had an opportunity to speak with Michael C. Barnes, Executive Director of CLAAD, about some of the obstacles and future trends that Life Sciences ADF drug manufacturers are facing today. Read his answers and begin to prepare for the FDA led discussions at CBI's Abuse-Deterrent Formulations Summit in March.

Read More

Topics: Compliance & Regulatory, Clinical, abuse deterrent formulations

Subscribe to CBI Scene Blog

Latest Posts